Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT PathwayMassimo Moro, Orazio Fortunato, Giulia Bertolini, et al.Journal for Immunotherapy of Cancer|September 29, 2023
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastomaChiara Brignole, Enzo Calarco, Veronica Bensa, et al.Plos One|January 14, 2014
Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3Caroline L Wilson, Jelena Mann, Meagan Walsh, et al.Journal of Hepatology|April 13, 2016
A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivoSaimir Luli, Daniela Di Paolo, Patrizia Perri, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2013
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastomaDaniela Di Paolo, Fabio Pastorino, Guendalina Zuccari, et al.Cancers|June 10, 2020
Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met InhibitionAdriana Amaro, Michela Croce, Silvano Ferrini, et al.Cancer Research|October 12, 2010
Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastomaChiara Brignole, Danilo Marimpietri, Daniela Di Paolo, et al.European Journal of Cancer (Oxford, England : 1990)|July 16, 2013
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicityAdriana Amaro, Valentina Mirisola, Giovanna Angelini, et al.Journal of Personalized Medicine|February 10, 2021
Potential Role of miRNAs in the Acquisition of Chemoresistance in NeuroblastomaBarbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, et al.Oncotarget|August 25, 2015
New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALKDaniela Di Paolo, D Yang, Fabio Pastorino, et al.Pageof 5